NSAID's
- The Jaw-Dropping Truth
by
Shane Ellison M.Sc.
All Rights Reserved
In an effort
to sell more drugs, medical ghost writing is the practice of paying
authors to write favorable drug reports for pharmaceutical companies.
The truth be known, medical ghost writing leads to mass deception among
medical doctors and declining health among prescription drug users.
Worse, it can also lead to needless deaths.
To better
illustrate the negative impacts of medical ghost writing we look to
Dr. M. Michael Wolfe. As a medical expert, editors of the Journalof
the American Medical Association (JAMA) sent him an unpublished drug
review on the arthritis medication Celebrex to evaluate. At first glance,
he was impressed by what he read.
It appeared
that after six months of a company-sponsored study involving more than
8,000 patients, the drug was associated with lower rates of stomach
and intestinal ulcers than two older arthritis medicines, diclofenac
and ibuprofen.
Feeling
confident that the drug was safe, Dr. Wolfe and colleagues wrote a favorable
editorial about Celebrex to accompany the newly released findings in
JAMA. Consequently, millions of M.D.'s began prescribing the now commonly
used Celebrex.
As time
passed, it was later learned that like many medical doctors of today,
Dr. Wolf was a victim of ghost writing. As fate would have it, Dr. Wolfe
later came across the complete data from the same study as a member
of the Food and Drug Administration's arthritis advisory committee.
Numerous discrepancies were seen between the initial report and the
newly found raw data.
Most notably,
Pharmacia, the manufacturers of Celebrex, made it appear as if the study
lasted only 6 months. In reality, the study of Celebrex lasted a year.
During the last half of the year (which was unreported) almost all of
the ulcer complications that occurred during the study were in Celebrex
users.
When all
of the data were considered, Dr. Wolfe stated that most of Celebrex's
apparent safety advantages disappeared. Unfortunately, JAMA had already
released the previously written findings that were derived from the
fabricated report along with Dr. Wolf's favorable editorial.
In an effort
to discover why the initial report did not illustrate the entire findings
of the study, Dr. Wolfe found that the study's 16 authors included faculty
members of eight medical schools. All authors were either employees
of Pharmacia or paid consultants of the company.
The Blatant
lies and disregard for patients health get's worse. Between 1990 and
1997 all clinical trials performed on non-steroidal anti-inflammatory
drugs (NSAIDS) such as Alleve, aspirin, Motrin, Ibuprofen, Bayer, celecoxib
--Celebrex®, diclofenac -- Voltaren®, etodolac --Lodine®,
fenoprofen -- Nalfon®, indomethacin -- Indocin®, ketoprofen
- Orudis®, Oruvail®, ketoralac --Toradol®, oxaprozin --
Daypro®, nabumetone -- Relafen®, sulindac -- Clinoril®,
tolmetin -- Tolectin®, rofecoxib -- Vioxx® were sponsored by
the drug manufacturer!
The result
was that 100% of the studies showed the sponsored drug to have equal
or superior efficacy when compared to other drugs.
The fallacies
behind medical ghost writing of NSAIDS are quickly exposed via increasing
body counts among users. Despite the fabricated studies showing NSAIDS
to be safe, real-life observations show that approximately 107,000 patients
are hospitalized every year for non steroidal anti-inflammatory drug-related
gastrointestinal complications.
Moreover,
at least 16,500 NSAID-related deaths occur each year among arthritis
patients. This figure, as reported by Dr. Gurkirpal Singh, is comparable
to the number of deaths from the acquired immunodeficiency syndrome
[AIDS] and shows that NSAIDS contribute to as many deaths as multiple
myeloma, asthma, and cervical cancer combined!
Although
outrageously high, the aforementioned statistics do not account for
over-the-counter use of NSAIDS. Thus, we can be confident that there
are considerably more deaths caused by the use of NSAIDS that go unreported.
And because
few medical doctors are unaware of these statistics, NSAIDS can rightfully
be considered a silent killer, especially when "experts" are
paid to write favorable reviews and drug manufacturers carry out their
own clinical studies.
Not being
aware of this silent killer, millions of American's are consuming NSAIDS
on a daily basis on the false hypothesis that they will successfully
enhance their longevity. This will go down in the history books as one
of America's deadliest health myths.
How many
people do you know who take an aspirin a day in an attempt to lower
their risk of heart disease? What about Celebrex?
Ghost writing
is a common, yet rarely mentioned practice among the drug industry.
Very few professionals and patients are able to get the real-scoop on
the drug they are either prescribing or consuming.
This further
illustrates the importance of seeking information about natural alternatives
which are not only effective but have killed less people than bee stings.
References
1. Okie,
Susan. Washington Post, August 5, 2001; Page A11
2. Ivan Oransky and Jeanne Lenzer. Ties to drug manufacturers deform
medical reviews. USA Today. McLean, Va.:Aug1, 2002. pg A. 11
3. Singh Gurkirpal, MD, "Recent Considerations in Nonsteroidal
Anti-Inflammatory Drug Gastropathy", The American Journal of Medicine,
July 27, 1998, p. 31S
4. Verrico MM, Weber RJ, McKaveney TP, Ansani NT, Towers AL. Adverse
Drug Events Involving COX-2 Inhibitors. Ann Pharmacother. 2003 Sep;37
(9):1203-13.
ABOUT THE
AUTHOR:
Shane Ellison
holds a Master's degree in organic chemistry and has first-hand industry
experience with drug research, design and synthesis. His web sites are
www.health-fx.net
and www.healthmyths.net.
Visit them for jaw-dropping facts about health, fitness and natural
medicine!